Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Heart Transplantation

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 126 articles:
HTML format



Single Articles


    April 2024
  1. JEEVANANDAM V
    Commentary: Warm ischemic injury to human donor hearts-when is it too much?
    J Thorac Cardiovasc Surg. 2024;167:1361-1362.
    PubMed    


  2. MONDAL NK, Li S, Elsenousi AE, Mattar A, et al
    Myocardial edema, inflammation, and injury in human heart donated after circulatory death are sensitive to warm ischemia and subsequent cold storage.
    J Thorac Cardiovasc Surg. 2024;167:1346-1358.
    PubMed     Abstract available


  3. WERT L, Stewart GC, Mehra MR, Milwidsky A, et al
    A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;167:1322-1330.
    PubMed     Abstract available


    March 2024
  4. ALNSASRA H, Perue RK, Khalil F, Regev O, et al
    Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS.
    J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00188.
    PubMed     Abstract available


  5. HONG Y, Hess NR, Ziegler LA, Hickey GW, et al
    Improved waitlist and comparable post-transplant outcomes in simultaneous heart-kidney transplantation under the 2018 heart allocation system.
    J Thorac Cardiovasc Surg. 2024;167:1064-1076.
    PubMed     Abstract available


  6. AZIZGOLSHANI N, Takeda K
    Commentary: What is the destination after left ventricular assist device under the new heart allocation system?
    J Thorac Cardiovasc Surg. 2024;167:1060-1061.
    PubMed    


  7. ZHANG A, Kurlansky P, Ning Y, Wang A, et al
    Outcomes following successful decannulation from extracorporeal life support for cardiogenic shock.
    J Thorac Cardiovasc Surg. 2024;167:1033-1046.
    PubMed     Abstract available


    February 2024

  8. Discussion to: Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
    J Thorac Cardiovasc Surg. 2024;167:544-546.
    PubMed    


  9. SINGH SK, Hassanein M, Ning Y, Wang C, et al
    Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
    J Thorac Cardiovasc Surg. 2024;167:535-543.
    PubMed     Abstract available


    January 2024
  10. ALEMANY VS, Nomoto R, Saeed MY, Celik A, et al
    Mitochondrial transplantation preserves myocardial function and viability in pediatric and neonatal pig hearts donated after circulatory death.
    J Thorac Cardiovasc Surg. 2024;167:e6-e21.
    PubMed     Abstract available


  11. SONG TH, Salerno CT
    Commentary: Blood type O, a bigger problem in the new heart allocation system?
    J Thorac Cardiovasc Surg. 2024;167:241-242.
    PubMed    


  12. ITAGAKI S, Toyoda N, Egorova N, Sun E, et al
    Total artificial heart implantation as a bridge to transplantation in the United States.
    J Thorac Cardiovasc Surg. 2024;167:205-214.
    PubMed     Abstract available


    December 2023
  13. KIRSCHNER M, Topkara VK, Sun J, Kurlansky P, et al
    Comparing 3-Year Survival and Readmissions between HeartMate 3 and Heart Transplant as Primary Treatment for Advanced Heart Failure.
    J Thorac Cardiovasc Surg. 2023 Dec 26:S0022-5223(23)01207.
    PubMed     Abstract available



  14. Discussion to: Simultaneous heart-kidney transplant compared with heart transplant alone in patients with borderline renal function who are not dialysis dependent.
    J Thorac Cardiovasc Surg. 2023 Dec 2:S0022-5223(23)01088.
    PubMed    


  15. TUME SC, Fuentes-Baldemar AA, Anders M, Spinner JA, et al
    Temporary ventricular assist device support with a catheter-based axial pump: Changing the paradigm at a pediatric heart center.
    J Thorac Cardiovasc Surg. 2023;166:1756-1763.
    PubMed     Abstract available


  16. THANGAPPAN K, Zafar F, Ahmed HF, Greenberg JW, et al
    Is the practice of using oversized organs for recipients with elevated pulmonary vascular resistance justified?
    J Thorac Cardiovasc Surg. 2023;166:1766-1779.
    PubMed     Abstract available


  17. GANAPATHI AM, Heh V, Rosenheck JP, Keller BC, et al
    Thoracic retransplantation: Does time to retransplantation matter?
    J Thorac Cardiovasc Surg. 2023;166:1529-1541.
    PubMed     Abstract available


    November 2023

  18. Discussion to: Donation after circulatory death improves probability of heart transplantation in candidates with posttransplant outcomes similar to those achieved with brain-dead donors.
    J Thorac Cardiovasc Surg. 2023 Nov 3:S0022-5223(23)00971.
    PubMed    


    October 2023
  19. CHO J, Tunuguntla HP, Tume SC, Spinner JA, et al
    Long-term Implantable Ventricular Assist Device Support in Children.
    J Thorac Cardiovasc Surg. 2023 Oct 30:S0022-5223(23)01005.
    PubMed     Abstract available


  20. SILVESTRY SC
    Commentary: The Evolving Market of Heart Transplantation.
    J Thorac Cardiovasc Surg. 2023 Oct 16:S0022-5223(23)00973.
    PubMed    


  21. FENG I, Wang AS, Takeda K, Topkara VK, et al
    Simultaneous Heart-Kidney Transplant Compared to Heart Transplant Alone in Non-Dialysis Dependent Patients with Borderline Renal Function.
    J Thorac Cardiovasc Surg. 2023 Oct 12:S0022-5223(23)00960.
    PubMed     Abstract available


  22. SCHUELER S, Bowles CT, Hinkel R, Wohlfarth R, et al
    A novel intrapericardial pulsatile device for individualized, biventricular circulatory support without direct blood contact.
    J Thorac Cardiovasc Surg. 2023;166:1119-1129.
    PubMed     Abstract available


    September 2023
  23. HESS NR, Hong Y, Yoon P, Bonatti J, et al
    Donation After Circulatory Death Improves Probability of Heart Transplantation in Waitlisted Candidates and Results in Post-Transplant Outcomes Similar to Those Achieved with Brain Dead Donors.
    J Thorac Cardiovasc Surg. 2023 Sep 13:S0022-5223(23)00787.
    PubMed     Abstract available


  24. BEATTIE MJ, Sleeper LA, Lu M, Teele SA, et al
    Factors associated with morbidity, mortality, and hemodynamic failure after biventricular conversion in borderline hypoplastic left hearts.
    J Thorac Cardiovasc Surg. 2023;166:933-942.
    PubMed     Abstract available


    July 2023
  25. MONGE MC, Joong A
    Commentary: Bridging the gap with temporary ventricular assist devices in pediatrics.
    J Thorac Cardiovasc Surg. 2023;166:212-213.
    PubMed    


    June 2023
  26. SCHRODER JN, Scheuer S, Catarino P, Caplan A, et al
    The American Association for Thoracic Surgery 2023 Expert Consensus Document: Adult cardiac transplantation utilizing donors after circulatory death.
    J Thorac Cardiovasc Surg. 2023 Jun 13:S0022-5223(23)00252.
    PubMed    


  27. ELDE S, He H, Lingala B, Baiocchi M, et al
    Analysis of the revised heart allocation policy and the influence of increased mechanical circulatory support on survival.
    J Thorac Cardiovasc Surg. 2023;165:2090-2103.
    PubMed     Abstract available


    May 2023
  28. SMERLING JL, Goldstone AB, Bacha EA, Liberman L, et al
    Long-term Outcomes of Tricuspid Valve Intervention During Stage 2 Palliation in Patients with a Single Right Ventricle.
    J Thorac Cardiovasc Surg. 2023 May 22:S0022-5223(23)00438.
    PubMed     Abstract available


    March 2023
  29. LEI I, Tang PC
    Commentary: Draining the cGAS from Immunity, advancing heart transplant surgery through a translational science approach.
    J Thorac Cardiovasc Surg. 2023 Mar 16:S0022-5223(23)00249.
    PubMed     Abstract available


  30. MANCINI D, Moss N
    Commentary: Bringing objectivity to the nonmedical evaluation of left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1123-1124.
    PubMed    


  31. OLT CK, Thuita LW, Soltesz EG, Tong MZ, et al
    Value of psychosocial evaluation for left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1111-1121.
    PubMed     Abstract available


  32. ROBERTSON G, Baran DA, Copeland H
    Commentary: In search of the "good candidate" for mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2023;165:1122-1123.
    PubMed    


    February 2023
  33. ZAKKO J, Premkumar A, Logan AJ, Sneddon JM, et al
    Textbook outcome: A novel metric in heart transplantation outcomes.
    J Thorac Cardiovasc Surg. 2023 Feb 23:S0022-5223(23)00178.
    PubMed     Abstract available


  34. RICHMOND ME, Deshpande SR, Zangwill SD, Bichell DP, et al
    Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults.
    J Thorac Cardiovasc Surg. 2023;165:460-468.
    PubMed     Abstract available


  35. GOERLICH CE, Griffith B, Hanna P, Hong SN, et al
    The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donors.
    J Thorac Cardiovasc Surg. 2023;165:e69-e81.
    PubMed     Abstract available


    January 2023
  36. BURATTO E, Konstantinov IE
    Commentary: Combined heart-lung procurement: Avoiding the bottleneck effect.
    J Thorac Cardiovasc Surg. 2023;165:197-198.
    PubMed    


  37. KIRKLIN JK
    Commentary: Hope for the failing heart awaiting multiorgan transplantation.
    J Thorac Cardiovasc Surg. 2023;165:183-184.
    PubMed    


  38. RAM E, Lavee J, Kassif Y, Peysakhovich Y, et al
    Primary heart dysfunction is greater with combined heart and lung compared with isolated heart procurement.
    J Thorac Cardiovasc Surg. 2023;165:186-195.
    PubMed     Abstract available


    December 2022
  39. KIRKLIN JK
    Commentary: Collateral impact of the HVAD decision and the path forward.
    J Thorac Cardiovasc Surg. 2022;164:1942-1943.
    PubMed    


  40. JAWAD K, Sipahi F, Koziarz A, Huhn S, et al
    Less-invasive ventricular assist device implantation: A multicenter study.
    J Thorac Cardiovasc Surg. 2022;164:1910-1918.
    PubMed     Abstract available


    November 2022
  41. SILVESTRY SC
    Commentary: Left ventricular assist device complications after heart transplantation: Then and now.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01173.
    PubMed    


    September 2022
  42. TANG PC, Haft JW, Lei I, Wang Z, et al
    Impact of donor blood type on outcomes after prolonged allograft ischemic times.
    J Thorac Cardiovasc Surg. 2022;164:981-993.
    PubMed     Abstract available


    August 2022
  43. EAPEN S, Nordan T, Critsinelis AC, Li B, et al
    Blood type O heart transplant candidates have longer waitlist time and higher delisting under the new allocation system.
    J Thorac Cardiovasc Surg. 2022 Aug 8. pii: S0022-5223(22)00826.
    PubMed     Abstract available


    July 2022
  44. SHAH AS
    Normothermic regional perfusion in donor heart recovery: Establishing a new normal.
    J Thorac Cardiovasc Surg. 2022;164:142-146.
    PubMed    


  45. TCHOUTA L, Drake D, Hoenerhoff M, Rojas-Pena A, et al
    Twenty-four-hour normothermic perfusion of isolated ex vivo hearts using plasma exchange.
    J Thorac Cardiovasc Surg. 2022;164:128-138.
    PubMed     Abstract available


  46. CHAMBERS DJ
    Commentary: Plasma exchange during extended normothermic ex vivo perfusion of donor hearts may lead to the Holy Grail of nonemergency transplantation!
    J Thorac Cardiovasc Surg. 2022;164:139-140.
    PubMed    


    June 2022
  47. SCHIAVON M, Camagni S, Venuta F, Rosso L, et al
    A multicentric evaluation of pediatric lung transplantation in Italy.
    J Thorac Cardiovasc Surg. 2022 Jun 20. pii: S0022-5223(22)00704.
    PubMed     Abstract available


  48. SHAFII A, Liao K, Ghanta RK
    Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall.
    J Thorac Cardiovasc Surg. 2022;163:2129-2130.
    PubMed    


    May 2022
  49. WELLS DA, Morales DLS
    Commentary: Set me free-cell-free DNA may soon provide reprieve to pediatric heart transplant recipients.
    J Thorac Cardiovasc Surg. 2022 May 28. pii: S0022-5223(22)00610.
    PubMed    


  50. CHEN Q, Emerson D, Megna D, Osho A, et al
    Heart transplantation using donation after circulatory death in the United States.
    J Thorac Cardiovasc Surg. 2022 May 15. pii: S0022-5223(22)00533.
    PubMed     Abstract available


  51. ROACH A, Trento A, Peiris A, Kobashigawa J, et al
    Trainee experience on ischemic times and outcomes following orthotopic heart transplantation.
    J Thorac Cardiovasc Surg. 2022 May 14. pii: S0022-5223(22)00604.
    PubMed     Abstract available


  52. BICHELL DP
    Commentary: The illogic of oversizing donor hearts for pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2022 May 11. pii: S0022-5223(22)00536.
    PubMed    


  53. LI SS, Osho A, Moonsamy P, D'Alessandro DA, et al
    Trends in the use of hepatitis C viremic donor hearts.
    J Thorac Cardiovasc Surg. 2022;163:1873-1885.
    PubMed     Abstract available


    April 2022
  54. KAWABORI M, Critsinelis AC, Patel S, Nordan T, et al
    Total ventricular mass oversizing +50% or greater was a predictor of worse 1-year survival after heart transplantation.
    J Thorac Cardiovasc Surg. 2022 Apr 30. pii: S0022-5223(22)00505.
    PubMed     Abstract available


  55. MAH KE, Morales DLS
    Commentary: The Vulcan mind MELD-XI.
    J Thorac Cardiovasc Surg. 2022;163:1477-1478.
    PubMed    


  56. BALSAM LB
    Commentary: The dilemma of donor heart cold storage: Are stem cell extracellular vesicles the answer?
    J Thorac Cardiovasc Surg. 2022;163:e294-e295.
    PubMed    


  57. WANG M, Yan L, Li Q, Yang Y, et al
    Mesenchymal stem cell secretions improve donor heart function following ex vivo cold storage.
    J Thorac Cardiovasc Surg. 2022;163:e277-e292.
    PubMed     Abstract available


    March 2022
  58. DANI A, Price N, Thangappan K, Ryan TD, et al
    Heart-kidney listing is better than isolated heart listing for pediatric heart transplant candidates with significant renal insufficiency.
    J Thorac Cardiovasc Surg. 2022 Mar 1. pii: S0022-5223(22)00221.
    PubMed     Abstract available


    February 2022
  59. KAKU Y, Takeda K, Naka Y
    Commentary: The role of mechanical circulatory support in heart retransplantation.
    J Thorac Cardiovasc Surg. 2022;163:723-724.
    PubMed    


  60. HAN JJ, Smood B, Atluri P
    Commentary: Vita nova or vanitas? Outcomes in cardiac retransplantation.
    J Thorac Cardiovasc Surg. 2022;163:721-722.
    PubMed    


  61. ZHU Y, Shudo Y, Lingala B, Baiocchi M, et al
    Outcomes after heart retransplantation: A 50-year single-center experience.
    J Thorac Cardiovasc Surg. 2022;163:712-720.
    PubMed     Abstract available


  62. CHAMBERS DJ
    Commentary: Heat shock protein 90 inhibition and donor heart protection-a paradoxical concept?
    J Thorac Cardiovasc Surg. 2022;163:e201-e202.
    PubMed    


  63. ACEROS H, Der Sarkissian S, Borie M, Pinto Ribeiro RV, et al
    Novel heat shock protein 90 inhibitor improves cardiac recovery in a rodent model of donation after circulatory death.
    J Thorac Cardiovasc Surg. 2022;163:e187-e197.
    PubMed     Abstract available


    January 2022
  64. KANG L, Markert ML, Turek JW
    Induction of donor-specific tolerance to heart transplantation: From concept to clinical translation.
    J Thorac Cardiovasc Surg. 2022 Jan 14. pii: S0022-5223(22)00028.
    PubMed    


  65. WOODS RK, Kirklin JK, Maeda K, Adachi I, et al
    We need better pediatric cardiac transplantation risk modeling.
    J Thorac Cardiovasc Surg. 2022 Jan 11. pii: S0022-5223(22)00016.
    PubMed    


  66. ALGAHIM MF
    Commentary: Being at the table, not on the menu: Surgeon-initiated call for better risk stratification of pediatric heart transplant recipients.
    J Thorac Cardiovasc Surg. 2022 Jan 11. pii: S0022-5223(22)00017.
    PubMed    


  67. ALSOUFI B
    Commentary: Heart transplantation listing for children with significant renal insufficiency: The need for a paradigm shift.
    J Thorac Cardiovasc Surg. 2022 Jan 8. pii: S0022-5223(22)00006.
    PubMed    


  68. POWER A, Jaquiss RDB
    Commentary: Donor-specific tolerance in heart transplantation: A marathon, not a sprint.
    J Thorac Cardiovasc Surg. 2022 Jan 8. pii: S0022-5223(22)00011.
    PubMed    


  69. DAVIES RR
    Commentary: Chicken or egg: Does risk-adjustment hide the deleterious consequences of bridging to transplant with temporary devices?
    J Thorac Cardiovasc Surg. 2022;163:149-150.
    PubMed    


  70. NIKOLOVA A, Youn JC, Kobashigawa JA
    Commentary: The anticlimax of the left ventricular assist devices-associated antibodies.
    J Thorac Cardiovasc Surg. 2022;163:136-137.
    PubMed    


  71. IYENGAR A, Smood BF, Atluri P
    Commentary: Fear of rejection: Acute cellular rejection after ventricular assist device placement.
    J Thorac Cardiovasc Surg. 2022;163:135-136.
    PubMed    


  72. BAKIR NH, Finnan MJ, MacGregor RM, Schilling JD, et al
    Cardiac allograft rejection in the current era of continuous flow left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;163:124-134.
    PubMed     Abstract available


    December 2021
  73. SADE RM, Carpenter AJ, D'Amico TA, Drake DH, et al
    Unethical studies on transplantation in cardiothoracic surgery journals.
    J Thorac Cardiovasc Surg. 2021;162:1647-1653.
    PubMed    


    October 2021
  74. HESS NR, Hickey GW, Sultan I, Kilic A, et al
    Redo orthotopic heart transplantation in the current era.
    J Thorac Cardiovasc Surg. 2021 Oct 30. pii: S0022-5223(21)01506.
    PubMed     Abstract available


  75. JEEVANANDAM V
    Commentary: Redo heart transplantation: Lessons learned over the past 20 years.
    J Thorac Cardiovasc Surg. 2021 Oct 6. pii: S0022-5223(21)01409.
    PubMed    


    September 2021
  76. BRAHMBHATT DH, Rao V
    Commentary: Bridge to bridge: No longer a bridge too far for successful cardiac transplant.
    J Thorac Cardiovasc Surg. 2021 Sep 29. pii: S0022-5223(21)01393.
    PubMed    


  77. NOLY PE, Moriguchi J, Shah KB, Anyanwu AC, et al
    A bridge-to-bridge approach to heart transplantation using extracorporeal membrane oxygenation and total artificial heart.
    J Thorac Cardiovasc Surg. 2021 Sep 20. pii: S0022-5223(21)01364.
    PubMed     Abstract available


  78. SMITH DE, Kon ZN, Carillo JA, Chen S, et al
    Early experience with donation after circulatory death heart transplantation using normothermic regional perfusion in the United States.
    J Thorac Cardiovasc Surg. 2021 Sep 14. pii: S0022-5223(21)01316.
    PubMed     Abstract available


  79. DUGGAL NM, Lei I, Wu X, Aaronson KD, et al
    Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures.
    J Thorac Cardiovasc Surg. 2021 Sep 14. pii: S0022-5223(21)01262.
    PubMed     Abstract available


    August 2021
  80. KILIC A
    Commentary: Left ventricular assist device therapy: The time is now.
    J Thorac Cardiovasc Surg. 2021;162:614-615.
    PubMed    


  81. SHUDO Y, Maeda K
    Commentary: Accepting only over-sized donors for adult congenital heart disease-Is it being overcautious?
    J Thorac Cardiovasc Surg. 2021;162:429-430.
    PubMed    


  82. DESHPANDE S, Alsoufi B
    Meeting needs-pushing boundaries: Mechanical circulatory support in children; year in review.
    J Thorac Cardiovasc Surg. 2021;162:400-404.
    PubMed    


  83. LAWRENCE KM, Ittenbach RF, Hunt ML, Kaplinski M, et al
    Attrition between the superior cavopulmonary connection and the Fontan procedure in hypoplastic left heart syndrome.
    J Thorac Cardiovasc Surg. 2021;162:385-393.
    PubMed     Abstract available


  84. PHILIP J, Powers E, Machado D, Colon DL, et al
    Pulsatile ventricular assist device as a bridge to transplant for the early high-risk single-ventricle physiology.
    J Thorac Cardiovasc Surg. 2021;162:405-413.
    PubMed     Abstract available


    June 2021
  85. KIRKLIN JK
    Commentary: Extracorporeal membrane oxygenation as a bridge to heart transplantation: Will we revisit Heisenberg's uncertainty principle and the observer effect?
    J Thorac Cardiovasc Surg. 2021 Jun 8. pii: S0022-5223(21)00898.
    PubMed    


  86. THOMPSON MP, Likosky DS
    Commentary: Can and should the National Inpatient Sample be used to evaluate trends in ventricular assist device use and outcomes?
    J Thorac Cardiovasc Surg. 2021;161:2093-2094.
    PubMed    


  87. SHARMA VJ, Iyengar AJ, Zannino D, Gentles T, et al
    Protein-losing enteropathy and plastic bronchitis after the Fontan procedure.
    J Thorac Cardiovasc Surg. 2021;161:2158-2165.
    PubMed     Abstract available


    May 2021
  88. IVEY-MIRANDA JB, Maulion C, Farrero-Torres M, Griffin M, et al
    Risk stratification of patients listed for heart transplantation while supported with extracorporeal membrane oxygenation.
    J Thorac Cardiovasc Surg. 2021 May 29. pii: S0022-5223(21)00877.
    PubMed     Abstract available


  89. DESHPANDE S, Sparks JD, Alsoufi B
    Pediatric heart transplantation: Year in review 2020.
    J Thorac Cardiovasc Surg. 2021 May 3. pii: S0022-5223(21)00758.
    PubMed    


  90. KNOPER RC, John R
    Commentary: The only constant is change: Understanding the changes in the new heart allocation system.
    J Thorac Cardiovasc Surg. 2021;161:1851-1852.
    PubMed    


  91. RAO V
    Commentary: The ethics of donor allocation.
    J Thorac Cardiovasc Surg. 2021;161:1849-1851.
    PubMed    


  92. LE AT, Mokadam NA
    Commentary: Flying too close to the sun.
    J Thorac Cardiovasc Surg. 2021;161:1848-1849.
    PubMed    


  93. ALAM A, Meyer DM, Hall SA
    Commentary: History is prologue: If we fail to learn from our past, we are doomed to repeat it.
    J Thorac Cardiovasc Surg. 2021;161:1847-1848.
    PubMed    


    April 2021
  94. CALLAHAN CP, Jegatheeswaran A, Barron DJ, Husain SA, et al
    Factors associated with mortality or transplantation versus Fontan completion after cavopulmonary shunt for patients with tricuspid atresia.
    J Thorac Cardiovasc Surg. 2021 Apr 30. pii: S0022-5223(21)00745.
    PubMed     Abstract available


  95. DARK JH, Mehew J, Venkateswaran R
    Prolongation of time from brain death to retrieval is beneficial to the donor heart.
    J Thorac Cardiovasc Surg. 2021;161:e311-e312.
    PubMed    


  96. JAWITZ OK, Raman V
    Reply from authors: Heart donor brain death duration-external validation from across the pond.
    J Thorac Cardiovasc Surg. 2021;161:e313.
    PubMed    


  97. LE AT, Mokadam NA
    Reply: Riding out the storm.
    J Thorac Cardiovasc Surg. 2021;161:e312-e313.
    PubMed    


  98. RASKIN A, Zafar F, Morales DLS
    Commentary: Is there life after cardiac death? Considering the challenges of heart donation after circulatory death.
    J Thorac Cardiovasc Surg. 2021;161:1344-1345.
    PubMed    


  99. KON ZN, Smith DE, Carillo JA, Moazami N, et al
    Commentary: The future is now-heart donation after circulatory death.
    J Thorac Cardiovasc Surg. 2021;161:1342-1343.
    PubMed    


    March 2021
  100. GANAPATHI AM, Lampert BC, Mokadam NA, Emani S, et al
    Allocation changes in heart transplantation: What has really changed?
    J Thorac Cardiovasc Surg. 2021 Mar 16. pii: S0022-5223(21)00510.
    PubMed     Abstract available


  101. CLEVELAND JC JR
    Commentary: Selecting the right cardiac donor.
    J Thorac Cardiovasc Surg. 2021;161:1061-1062.
    PubMed    


  102. KAWABORI M, Critsinelis AC, Hironaka CE, Chen FY, et al
    Right ventricular undersizing is associated with increased 1-year mortality.
    J Thorac Cardiovasc Surg. 2021;161:1048-1059.
    PubMed     Abstract available


    February 2021
  103. WOODS RK
    Commentary: The Fontan cardiac transplant-Time to embrace change.
    J Thorac Cardiovasc Surg. 2021 Feb 23. pii: S0022-5223(21)00367.
    PubMed    


  104. AMDANI S, Simpson KE, Thrush P, Shih R, et al
    Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
    J Thorac Cardiovasc Surg. 2021 Feb 18. pii: S0022-5223(21)00262.
    PubMed     Abstract available


  105. OVERBEY DM, Lodge AJ
    Commentary: Neonatal heart transplant: A good option in a bad situation.
    J Thorac Cardiovasc Surg. 2021 Feb 12. pii: S0022-5223(21)00260.
    PubMed    


  106. MELEHY A, Sanchez JE, Nemeth SK, Kurlansky PA, et al
    National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2021 Feb 5. pii: S0022-5223(21)00213.
    PubMed     Abstract available


  107. BICHELL DP
    Commentary: The importance and treachery of patient selection for neonatal heart transplant.
    J Thorac Cardiovasc Surg. 2021 Feb 5. pii: S0022-5223(21)00240.
    PubMed    


  108. IUS F, Moscalenco D, Boethig D, Tudorache I, et al
    Cardiac valve operations after solid organ transplantation: A single-center experience.
    J Thorac Cardiovasc Surg. 2021;161:595-606.
    PubMed     Abstract available


    January 2021
  109. ECKHAUSER A
    Commentary: Neonatal heart transplant: Conservation status-critically endangered.
    J Thorac Cardiovasc Surg. 2021 Jan 30. pii: S0022-5223(21)00197.
    PubMed    


  110. LIN Y, Davis TJ, Zorrilla-Vaca A, Wojcik BM, et al
    Neonatal heart transplant outcomes: A single institutional experience.
    J Thorac Cardiovasc Surg. 2021 Jan 23. pii: S0022-5223(21)00130.
    PubMed     Abstract available


  111. GUARIENTO A, Blitzer D, Vida V
    Commentary: Donor selection in heart transplantation: It's a match!
    J Thorac Cardiovasc Surg. 2021 Jan 19. pii: S0022-5223(21)00107.
    PubMed    


    December 2020
  112. MONDAL NK, Ghanta RK
    Commentary: Getting better with every beat. Extending the clock with ex vivo perfusion for heart transplantation.
    J Thorac Cardiovasc Surg. 2020 Dec 25. pii: S0022-5223(20)33422.
    PubMed    


  113. WITER L, Kilic A
    Commentary: Proceed with caution: Right ventricular undersizing in heart transplant.
    J Thorac Cardiovasc Surg. 2020 Dec 13. pii: S0022-5223(20)33358.
    PubMed    


    November 2020
  114. RIGGS KW, Morales DLS, Zafar F
    Commentary: Is two ever better than one in pediatric ventricular assist device support? The controversy continues.
    J Thorac Cardiovasc Surg. 2020;160:1309-1310.
    PubMed    


  115. DYKES JC, Maeda K
    Commentary: To BiVAD or not to BiVAD...that is the question?
    J Thorac Cardiovasc Surg. 2020;160:1310-1311.
    PubMed    


    October 2020
  116. AHMED H, Anderson JB, Bates KE, Fleishman CE, et al
    Development of a validated risk score for interstage death or transplant after stage I palliation for single-ventricle heart disease.
    J Thorac Cardiovasc Surg. 2020;160:1021-1030.
    PubMed     Abstract available


    September 2020
  117. IBRAHIM M, Kilic A
    Commentary: Heart transplantation using hepatitis C-positive donors: What are we waiting for?
    J Thorac Cardiovasc Surg. 2020 Sep 18. pii: S0022-5223(20)32652.
    PubMed    


  118. SILVESTRY SC
    Commentary: Moving forward, looking back: Lessons from coronavirus disease 2019 (COVID-19) for preparedness in advanced heart failure programs.
    J Thorac Cardiovasc Surg. 2020 Sep 9. pii: S0022-5223(20)32581.
    PubMed    


  119. MEHAFFEY JH, Hawkins RB
    Commentary: Building bridges to the future of heart transplantation.
    J Thorac Cardiovasc Surg. 2020 Sep 4. pii: S0022-5223(20)32559.
    PubMed    


  120. SOLTESZ EG
    Commentary: From the trenches: Lessons on caring for patients with heart failure during coronavirus disease 2019 (COVID-19).
    J Thorac Cardiovasc Surg. 2020 Sep 4. pii: S0022-5223(20)32567.
    PubMed    


  121. BANSAL A, Goldstein D, Schettle S, Pepitone S, et al
    Institutional preparedness strategies for heart failure, durable left ventricular assist device, and heart transplant patients during the Coronavirus Disease 2019 (COVID-19) pandemic.
    J Thorac Cardiovasc Surg. 2020 Sep 2. pii: S0022-5223(20)32490.
    PubMed    


    May 2020
  122. BARTFAY SE, Dellgren G, Hallhagen S, Wahlander H, et al
    Durable circulatory support with a paracorporeal device as an option for pediatric and adult heart failure patients.
    J Thorac Cardiovasc Surg. 2020 May 15. pii: S0022-5223(20)31166.
    PubMed     Abstract available


    February 2020
  123. HAFT JW
    Commentary: Can we finally move the needle in organ donation?
    J Thorac Cardiovasc Surg. 2020;159:514.
    PubMed    


  124. IYENGAR A, Atluri P
    Commentary: Keeping your cool: Donor heart preservation using the SherpaPak Cardiac Transport System.
    J Thorac Cardiovasc Surg. 2020;159:e125-e126.
    PubMed    


  125. MOAYEDI Y, Gulamhusein AF, Khush KK
    Treading lightly as we step into a new era: Use of hepatitis C virus-infected organs for transplantation.
    J Thorac Cardiovasc Surg. 2020;159:505-510.
    PubMed    


  126. NAITO N, Funamoto M, Pierson RN, D'Alessandro DA, et al
    First clinical use of a novel hypothermic storage system for a long-distance donor heart procurement.
    J Thorac Cardiovasc Surg. 2020;159:e121-e123.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Heart Transplantation is free of charge.